BDXBecton Dickinson
Is the price fair?
Neither cheap nor expensive: nothing decisive, though at the top of its own P/E range.
Expensive vs its own history: P/E 55.3 vs a 34.2 median over 39 quarters (+62% vs median).
Sector median 22.6× across 130 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What BDX's price assumes
Becton Dickinson trades at 55.3× earnings against 39.6× for the median Medical Instruments & Supplies name, more expensive than its own group.
Trailing P/E · Medical Instruments & Supplies median 39.6 · 1.40× the median: the market pays up for this one
- Price / sales
- 1.71
Price / sales · today's price, trailing year to Jun 30, 2026
- Price / book
- 1.62
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 2.40
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 1.62
- EV / EBITtoday's price, trailing year to Jun 30, 2026
- 22.5
- EV / salestoday's price, trailing year to Jun 30, 2026
- 2.40
- Healthcare median P/E509 names
- 26.2
- Medical Instruments & Supplies median P/E33 names
- 39.6
- Market capitalisation
- $39.7B
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $92.85 |
| Its own P/E history, median | $113.63 |
| Its own P/E history, upper quartile | $147.08 |
| 52-week range | $136.09 – $192.00 |
| Today | $183.72 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
The closest names by size in the same industry